首页> 美国卫生研究院文献>The Journal of Biological Chemistry >MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells
【2h】

MicroRNA-9 Inhibition of Cell Proliferation and Identification of Novel miR-9 Targets by Transcriptome Profiling in Breast Cancer Cells

机译:MicroRNA-9抑制细胞增殖并通过转录组分析在乳腺癌细胞中鉴定新型miR-9靶标

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although underexpression of miR-9 in cancer cells is reported in many cancer types, it is currently difficult to classify miR-9 as a tumor suppressor or an oncomir. We demonstrate that miR-9 expression is down-regulated in MCF-7 and MDA-MB-231 breast cancer cells compared with MCF-10-2A normal breast cell line. Increasing miR-9 expression levels in breast cancer cells induced anti-proliferative, anti-invasive, and pro-apoptotic activity. In addition, microarray profiling of the transcriptome of MCF-7 cells overexpressing miR-9 identified six novel direct miR-9 targets (AP3B1, CCNG1, LARP1, MTHFD1L, MTHFD2, and SRPK1). Among these, MTHFD2 was identified as a miR-9 target gene that affects cell proliferation. Knockdown of MTHFD2 mimicked the effect observed when miR-9 was overexpressed by decreasing cell viability and increasing apoptotic activity. Despite variable effects on different cell lines, proliferative and anti-apoptotic activity of MTHFD2 was demonstrated whereby it could escape from miR-9-directed suppression (by overexpression of MTHFD2 with mutated miR-9 binding sites). Furthermore, endogenous expression levels of miR-9 and MTHFD2 displayed inverse expression profiles in primary breast tumor samples compared with normal breast samples; miR-9 was down-regulated, and MTHFD2 was up-regulated. These results indicate anti-proliferative and pro-apoptotic activity of miR-9 and that direct targeting of MTHFD2 can contribute to tumor suppressor-like activity of miR-9 in breast cancer cells.
机译:尽管在许多类型的癌症中都报告了miR-9在癌细胞中的表达不足,但是目前很难将miR-9归类为肿瘤抑制因子或后遗症。我们证明,与MCF-10-2A正常乳腺癌细胞系相比,miR-9在MCF-7和MDA-MB-231乳腺癌细胞中的表达下调。乳腺癌细胞中miR-9表达水平的提高诱导了抗增殖,抗侵袭和促凋亡活性。此外,微表达miR-9的MCF-7细胞转录组的微阵列分析确定了六个新的直接miR-9靶标(AP3B1,CCNG1,LARP1,MTHFD1L,MTHFD2和SRPK1)。其中,MTHFD2被鉴定为影响细胞增殖的miR-9靶基因。降低细胞存活率和增加细胞凋亡活性可以降低MTHFD2的表达,从而模拟miR-9过表达时的效果。尽管对不同细胞系具有不同的影响,但已证明MTHFD2的增殖和抗凋亡活性可逃避miR-9定向的抑制(通过具有突变miR-9结合位点的MTHFD2的过表达)。此外,与正常乳腺样品相比,miR-9和MTHFD2的内源性表达水平在原发性乳腺肿瘤样品中显示出相反的表达谱。 miR-9下调,MTHFD2上调。这些结果表明miR-9的抗增殖和促凋亡活性,并且直接靶向MTHFD2可以促进乳腺癌细胞中miR-9的肿瘤抑制样活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号